[QT interval and drugs. Recommendation for drug prescription for patients with long QT syndrome. Clinical Research Group of INSERM 4940 12: Diagnostic Clinic of Congenital Long QT Syndrome].

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Archives des maladies du coeur et des vaisseaux

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 9749265
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CONGENITAL DEAF‐MUTISM, FUNCTIONAL HEART DISEASE WITH PROLONGATION OF THE Q‐T INTERVAL, AND SUDDEN DEATH

  1999cited by this paper
• QT interval prolongation and risk of life-threatening arrhythmias during toxoplasmosis prophylaxis with spiramycin in neonates.

  1997cited by this paper
• [Torsades de pointe with spiramycine and metiquazine therapy. Apropos of a case].

  1997cited by this paper
• A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome

  1997cited by this paper
• A mutation in HERG associated with notched T waves in long QT syndrome.

  1996cited by this paper
• Pathophysiology of ion channel mutations.

  1996cited by this paper
• Sex difference in risk of torsade de pointes with d,l-sotalol.

  1996cited by this paper
• KvLQT1 and IsK (minK) proteins associate to form the IKS cardiac potassium current

  1996cited by this paper
• Erythromycin-induced cardiac toxicity.

  1995cited by this paper
• Mapping of a gene for long QT syndrome to chromosome 4q25-27.

  1995cited by this paper
• Amiodarone-associated Proarrhythmic Effects: A Review with Special Reference to Torsade de Pointes Tachycardia

  1994cited by this paper
• [Torsades de pointes].

  1993cited by this paper
• Mechanism of the cardiotoxic actions of terfenadine.

  1993cited by this paper
• Experimental models of torsades de pointes

  1992cited by this paper
• Torsades de Pointes after treatment with terfenadine and ketoconazole.

  1992cited by this paper
• Linkage of a cardiac arrhythmia, the long QT syndrome, and the Harvey ras-1 gene.

  1991cited by this paper
• Propafenone‐Induced Torsade de Pointes: Cross‐Reactivity with Quinidine

  1991cited by this paper
• Pentamidine-induced torsade de pointes.

  1991cited by this paper
• [QT prolongation and induction of torsades de pointe by flecainide. Apropos of a case].

  1988cited by this paper
• [Electrophysiological study of pro-arrhythmogenic effects of erythromycin].

  1988cited by this paper
• Torsade de pointes due to quinidine: observations in 31 patients.

  1984cited by this paper
• Thioridazine (mellaril)-induced ventricular tachycardia controlled with an artificial pacemaker.

  1966cited by this paper

• [Arrhythmogenic effects of non cardiovascular drugs].

  2003cites this paper
• [Value of genetic testing in the management of the congenital long QT syndrome].

  2003cites this paper
• [Genetics and cardiac arrhythmias].

  2003cites this paper
• [Congenital long QT syndrome in newborns].

  2002cites this paper
• [Role of antiarrhythmics in the treatment of paroxysmal atrial fibrillation].

  2002cites this paper
• [Minimizing the risks associated with QTc prolongation in people with schizophrenia. A consensus statement by the Cardiac Safety in Schizophrenia Group].

  2002cites this paper
• [Congenital long QT syndrome].

  2001cites this paper
• [Citalopram and Torsades de Pointes. A case report].

  2001cites this paper
• [Cardiac consequences of adolescent anorexia nervosa].

  2001cites this paper
• [Bepridil: importance of serum level in treatment surveillance].

  2000cites this paper
• Intervalo QTU prolongado durante el uso de cisapride

  2000cites this paper
• [Antipsychotic drugs and cardiovascular safety: current studies of prolonged QT interval and risk of ventricular arrhythmia].

  2000cites this paper
• [Cardiac side effects of anti-HIV agents].

  2000cites this paper
• [Congenital long QT syndrome. The value of genetics in prognostic evaluation].

  1999cites this paper
• Electrophysiological effects of cetirizine, astemizole and d‐sotalol in a canine model of long QT syndrome

  1999cites this paper
• [Congenital long QT syndrome].

  1998cites this paper